CATERPILLAR INC. financials

  1. Home
  2. Company Facts
  3. CAT
CAT CIK 0000018230

Source: EDGAR filings · raw companyfacts JSON · Built 2026-04-25T09:57:15Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Free Cash Flow 8.92B 10.05B 11.29B 6.47B 6.11B 5.35B
EBITDA 13.41B 15.22B 15.11B 10.12B 9.23B 6.99B
Working Capital 15.93B 13.41B 12.22B 12.25B 13.61B 13.75B
Net Debt 26.96B 25.46B 22.71B 25.25B 22.82B 19.28B
Gross Margin 99.93% 99.95% 99.76% 99.31% 30.33% 6.67%
Operating Margin 16.50% 20.17% 19.33% 13.30% 13.49% 10.91%
Net Margin 13.14% 16.65% 15.41% 11.28% 12.74% 7.19%
Return on Equity (ROE) 41.66% 55.34% 52.98% 42.19% 39.31% 19.53%
Return on Assets (ROA) 9.01% 12.29% 11.81% 8.18% 7.84% 3.83%
Current Ratio 1.4357 1.4155 1.3519 1.3886 1.4559 1.5345
Debt-to-Equity 1.7327 1.6593 1.5223 2.0295 1.9423 1.862
Effective Tax Rate 23.98% 19.66% 21.31% 23.62% 21.23% 25.18%
Cash Conversion Ratio 1.3217 1.1156 1.2471 1.1584 1.1086 2.1069
Accruals Ratio -0.029 -0.0142 -0.0292 -0.013 -0.0085 -0.0424
SBC % of Revenue 0.36% 0.34% 0.31% 0.32% 0.39% 0.48%
CapEx Coverage 4.1613 6.0538 8.0683 5.9923 6.5855 6.4693
Free Cash Flow Per Share $18.88 $20.53 $21.98 $12.20 $11.13 $9.75

Valuation Metrics

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
P/E Trailing (Diluted) 30.4556 16.4517 14.6953 18.9525 17.4759 33.337
P/FCF 30.3393 17.6704 13.4529 19.6388 18.5744 18.6681
FCF Yield 3.30% 5.66% 7.43% 5.09% 5.38% 5.36%
EV / EBITDA 21.8828 13.0588 11.2752 14.7121 14.4764 16.9703
P/S 3.9438 2.675 2.2019 2.0813 2.1736 2.3775
P/B 12.5038 8.8931 7.571 7.7833 6.7082 6.4544

Income Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Revenues 67.59B 64.81B 67.06B 59.43B 50.97B 41.75B
Cost of Goods and Services Sold 49.00M 33.00M 160.00M 413.00M — —
Cost of Revenue 44.75B 40.20B 42.77B 41.35B 35.51B 29.08B
Gross Profit — — — — — 2.79B
Research and Development Expense 2.15B 2.11B 2.11B 1.81B 1.69B 1.42B
Selling, General and Administrative Expense 6.99B 6.67B 6.37B 5.65B 5.37B 4.64B
Operating Income (Loss) 11.15B 13.07B 12.97B 7.90B 6.88B 4.55B
Income Tax Expense (Benefit) 2.77B 2.63B 2.78B 2.07B 1.74B 1.01B
Earnings Per Share, Basic $18.90 $22.17 $20.24 $12.72 $11.93 $5.51
Weighted Average Number of Shares Outstanding, Basic 470.00M 486.70M 510.60M 526.90M 544.00M 544.10M
Earnings Per Share, Diluted $18.81 $22.05 $20.12 $12.64 $11.83 $5.46
Weighted Average Number of Shares Outstanding, Diluted 472.30M 489.40M 513.60M 530.40M 548.50M 548.60M

Balance Sheet

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Cash and Cash Equivalents, at Carrying Value 9.98B 6.89B 6.98B 7.00B 9.25B 9.35B
Assets, Current 52.48B 45.68B 46.95B 43.78B 43.45B 39.46B
Assets 98.58B 87.76B 87.48B 81.94B 82.79B 78.32B
Liabilities, Current 36.56B 32.27B 34.73B 31.53B 29.85B 25.72B
Long-term Debt, Excluding Current Maturities 30.70B 27.35B 24.47B 25.71B 26.03B 26.00B
Liabilities 77.27B 68.27B 67.97B 66.05B 66.28B 62.95B
Common Stock, Shares, Outstanding 465.30M 477.90M 499.40M 516.30M 535.90M 545.30M

Cash Flow Statement

Concept FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash Provided by (Used in) Operating Activities 11.74B 12.04B 12.88B 7.77B 7.20B 6.33B
Payments to Acquire Property, Plant, and Equipment 2.82B 1.99B 1.60B 1.30B 1.09B 978.00M
Net Cash Provided by (Used in) Investing Activities -4.71B -2.45B -5.87B -2.54B -3.08B -1.49B
Payments for Repurchase of Common Stock 5.19B 7.70B 4.97B 4.23B 2.67B 1.13B
Net Cash Provided by (Used in) Financing Activities -3.90B -9.56B -6.93B -7.28B -4.19B -3.75B

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Income Statement

32 concepts 3 units
Unit US$ · 26 concepts
Label Value Period
Other Operating Income (Expense), Net -1.19B 2025-01-01 → 2025-12-31
Lease Income 1.69B 2025-01-01 → 2025-12-31
Operating Lease, Lease Income 1.22B 2025-01-01 → 2025-12-31
Sales-type Lease, Revenue 473.00M 2025-01-01 → 2025-12-31
Revenues 67.59B 2025-01-01 → 2025-12-31
Financing Receivable, Credit Loss, Expense (Reversal) 109.00M 2025-01-01 → 2025-12-31
Cost of Goods and Services Sold 49.00M 2025-01-01 → 2025-12-31
Cost of Revenue 44.75B 2025-01-01 → 2025-12-31
Costs and Expenses 56.44B 2025-01-01 → 2025-12-31
Research and Development Expense 2.15B 2025-01-01 → 2025-12-31
Amortization of Intangible Assets 169.00M 2025-01-01 → 2025-12-31
Restructuring Charges 448.00M 2025-01-01 → 2025-12-31
Goodwill, Impairment Loss 0 2025-01-01 → 2025-12-31
Selling, General and Administrative Expense 6.99B 2025-01-01 → 2025-12-31
Operating Income (Loss) 11.15B 2025-01-01 → 2025-12-31
Gain (Loss) on Derivative Instruments, Net, Pretax 10.00M 2025-01-01 → 2025-12-31
Royalty Income, Nonoperating 143.00M 2025-01-01 → 2025-12-31
Investment Income, Net 416.00M 2025-01-01 → 2025-12-31
Foreign Currency Transaction Gain (Loss), before Tax -168.00M 2025-01-01 → 2025-12-31
Other Nonoperating Income (Expense) 892.00M 2025-01-01 → 2025-12-31
Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest 11.54B 2025-01-01 → 2025-12-31
Income (Loss) from Equity Method Investments 109.00M 2025-01-01 → 2025-12-31
Income Tax Expense (Benefit) 2.77B 2025-01-01 → 2025-12-31
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 8.88B 2025-01-01 → 2025-12-31
Net Income (Loss) Attributable to Noncontrolling Interest -2.00M 2025-01-01 → 2025-12-31
Net Income (Loss) Available to Common Stockholders, Basic 8.88B 2025-01-01 → 2025-12-31
Unit shares · 3 concepts
Label Value Period
Weighted Average Number of Shares Outstanding, Basic 470.00M 2025-01-01 → 2025-12-31
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 100,000 2025-01-01 → 2025-12-31
Weighted Average Number of Shares Outstanding, Diluted 472.30M 2025-01-01 → 2025-12-31
Unit US$ / share · 3 concepts
Label Value Period
Earnings Per Share, Basic $18.90 2025-01-01 → 2025-12-31
Earnings Per Share, Diluted $18.81 2025-01-01 → 2025-12-31
Common Stock, Dividends, Per Share, Declared $5.94 2025-01-01 → 2025-12-31

Comprehensive Income

8 concepts 1 unit
Unit US$ · 8 concepts
Label Value Period
Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax 557.00M 2025-01-01 → 2025-12-31
Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax 9.00M 2025-01-01 → 2025-12-31
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax 66.00M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax 85.00M 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent 85.00M 2025-01-01 → 2025-12-31
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9.58B 2025-01-01 → 2025-12-31
Other Comprehensive Income (Loss), Net of Tax 699.00M 2025-01-01 → 2025-12-31
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest 9.58B 2025-01-01 → 2025-12-31

Balance Sheet

52 concepts 3 units
Unit US$ · 47 concepts
Label Value Period
Cash and Cash Equivalents, at Carrying Value 9.98B as of 2025-12-31
Accounts Receivable, after Allowance for Credit Loss, Current 10.92B as of 2025-12-31
Debt Securities, Available-for-sale 3.55B as of 2025-12-31
Financing Receivable, after Allowance for Credit Loss, Current 10.65B as of 2025-12-31
Inventory, LIFO Reserve 4.30B as of 2025-12-31
Inventory, Net 18.14B as of 2025-12-31
Financing Receivable, before Allowance for Credit Loss 25.15B as of 2025-12-31
Financing Receivable, Allowance for Credit Loss 277.00M as of 2025-12-31
Assets, Current 52.48B as of 2025-12-31
Operating Lease, Right-of-Use Asset 708.00M as of 2025-12-31
Property, Plant and Equipment, Gross 31.91B as of 2025-12-31
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 16.77B as of 2025-12-31
Property, Plant and Equipment, Net 15.14B as of 2025-12-31
Contract with Customer, Asset, after Allowance for Credit Loss 297.00M as of 2025-12-31
Accounts Receivable, after Allowance for Credit Loss, Noncurrent 2.14B as of 2025-12-31
Financing Receivable, after Allowance for Credit Loss, Noncurrent 14.27B as of 2025-12-31
Dividends Payable, Current 703.00M as of 2025-12-31
Goodwill 5.32B as of 2025-12-31
Finite-Lived Intangible Assets, Gross 2.61B as of 2025-12-31
Finite-Lived Intangible Assets, Accumulated Amortization 2.37B as of 2025-12-31
Finite-Lived Intangible Assets, Net 241.00M as of 2025-12-31
Intangible Assets, Net (Excluding Goodwill) 241.00M as of 2025-12-31
Other Assets, Noncurrent 6.10B as of 2025-12-31
SupplierFinanceProgramObligation 936.00M as of 2025-12-31
Contract with Customer, Liability 4.68B as of 2025-12-31
Operating Lease, Liability 728.00M as of 2025-12-31
Assets 98.58B as of 2025-12-31
Long-term Line of Credit 771.00M as of 2025-12-31
Accounts Payable, Current 8.97B as of 2025-12-31
SupplierFinanceProgramObligationCurrent 936.00M as of 2025-12-31
Employee-related Liabilities, Current 2.55B as of 2025-12-31
Accrued Liabilities, Current 5.59B as of 2025-12-31
Contract with Customer, Liability, Current 3.31B as of 2025-12-31
Short-term Debt 5.51B as of 2025-12-31
Other Liabilities, Current 2.80B as of 2025-12-31
Liabilities, Current 36.56B as of 2025-12-31
Long-term Debt, Excluding Current Maturities 30.70B as of 2025-12-31
Deferred Income Tax Liabilities, Net 494.00M as of 2025-12-31
Other Liabilities, Noncurrent 6.17B as of 2025-12-31
Operating Lease, Liability, Noncurrent 570.00M as of 2025-12-31
Liabilities 77.27B as of 2025-12-31
Treasury Stock, Value 49.54B as of 2025-12-31
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.77B as of 2025-12-31
Retained Earnings (Accumulated Deficit) 65.45B as of 2025-12-31
Stockholders' Equity Attributable to Noncontrolling Interest 0 as of 2025-12-31
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 21.32B as of 2025-12-31
Liabilities and Equity 98.58B as of 2025-12-31
Unit shares · 4 concepts
Label Value Period
Common Stock, Shares Authorized 2.00B as of 2025-12-31
Common Stock, Shares, Issued 814.89M as of 2025-12-31
Common Stock, Shares, Outstanding 465.30M as of 2025-12-31
Treasury Stock, Common, Shares 349.61M as of 2025-12-31
Unit US$ / share · 1 concept
Label Value Period
Common Stock, Par or Stated Value Per Share $1.00 as of 2025-12-31

Cash Flow Statement

42 concepts 1 unit
Unit US$ · 42 concepts
Label Value Period
Income Taxes Paid 2.21B 2025-01-01 → 2025-12-31
Depreciation 2.09B 2025-01-01 → 2025-12-31
Depreciation, Depletion and Amortization 2.26B 2025-01-01 → 2025-12-31
Operating Lease, Payments 185.00M 2025-01-01 → 2025-12-31
Restructuring Costs 445.00M 2025-01-01 → 2025-12-31
Interest Paid, Excluding Capitalized Interest, Operating Activities 1.84B 2025-01-01 → 2025-12-31
Deferred Income Tax Expense (Benefit) 465.00M 2025-01-01 → 2025-12-31
IncomeTaxPaidFederalAfterRefundReceived 605.00M 2025-01-01 → 2025-12-31
IncomeTaxPaidStateAndLocalAfterRefundReceived 138.00M 2025-01-01 → 2025-12-31
Income Taxes Paid, Net 2.21B 2025-01-01 → 2025-12-31
Other Noncash Income (Expense) -742.00M 2025-01-01 → 2025-12-31
Increase (Decrease) in Receivables 2.14B 2025-01-01 → 2025-12-31
Increase (Decrease) in Inventories 1.48B 2025-01-01 → 2025-12-31
Increase (Decrease) in Other Operating Assets 176.00M 2025-01-01 → 2025-12-31
Increase (Decrease) in Contract with Customer, Liability 1.93B 2025-01-01 → 2025-12-31
Increase (Decrease) in Accounts Payable 1.18B 2025-01-01 → 2025-12-31
Increase (Decrease) in Employee Related Liabilities 187.00M 2025-01-01 → 2025-12-31
Increase (Decrease) in Accrued Liabilities 438.00M 2025-01-01 → 2025-12-31
Increase (Decrease) in Other Operating Liabilities -294.00M 2025-01-01 → 2025-12-31
Net Cash Provided by (Used in) Operating Activities 11.74B 2025-01-01 → 2025-12-31
Payments to Acquire Property, Plant, and Equipment 2.82B 2025-01-01 → 2025-12-31
Payments to Acquire Equipment on Lease 1.47B 2025-01-01 → 2025-12-31
Proceeds from Sale of Property, Plant, and Equipment 708.00M 2025-01-01 → 2025-12-31
Payments to Acquire Marketable Securities 1.93B 2025-01-01 → 2025-12-31
Payments to Acquire Finance Receivables 15.33B 2025-01-01 → 2025-12-31
Proceeds from Sale of Debt Securities, Available-for-sale 2.17B 2025-01-01 → 2025-12-31
Proceeds from Sale and Maturity of Marketable Securities 2.49B 2025-01-01 → 2025-12-31
Proceeds from Sale of Finance Receivables 71.00M 2025-01-01 → 2025-12-31
Proceeds from Collection of Finance Receivables 13.52B 2025-01-01 → 2025-12-31
Payments to Acquire Businesses, Net of Cash Acquired 47.00M 2025-01-01 → 2025-12-31
Proceeds from Divestiture of Businesses, Net of Cash Divested 22.00M 2025-01-01 → 2025-12-31
Payments for (Proceeds from) Other Investing Activities -75.00M 2025-01-01 → 2025-12-31
Net Cash Provided by (Used in) Investing Activities -4.71B 2025-01-01 → 2025-12-31
Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less 1.11B 2025-01-01 → 2025-12-31
Proceeds from Issuance or Sale of Equity -16.00M 2025-01-01 → 2025-12-31
Payments for Repurchase of Common Stock 5.19B 2025-01-01 → 2025-12-31
Payments of Ordinary Dividends, Common Stock 2.75B 2025-01-01 → 2025-12-31
Proceeds from (Payments for) Other Financing Activities -1.00M 2025-01-01 → 2025-12-31
Net Cash Provided by (Used in) Financing Activities -3.90B 2025-01-01 → 2025-12-31
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents -43.00M 2025-01-01 → 2025-12-31
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.09B 2025-01-01 → 2025-12-31
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.99B as of 2025-12-31

Notes

153 concepts 6 units
Unit US$ · 132 concepts
Label Value Period
Current Federal Tax Expense (Benefit) 804.00M 2025-01-01 → 2025-12-31
Current State and Local Tax Expense (Benefit) 109.00M 2025-01-01 → 2025-12-31
Current Foreign Tax Expense (Benefit) 1.39B 2025-01-01 → 2025-12-31
Current Income Tax Expense (Benefit) 2.30B 2025-01-01 → 2025-12-31
Deferred Federal Income Tax Expense (Benefit) 393.00M 2025-01-01 → 2025-12-31
Deferred State and Local Income Tax Expense (Benefit) 16.00M 2025-01-01 → 2025-12-31
Deferred Foreign Income Tax Expense (Benefit) 56.00M 2025-01-01 → 2025-12-31
Operating Lease, Liability, Current 158.00M as of 2025-12-31
Prepaid Expense and Other Assets, Current 2.80B as of 2025-12-31
Share-based Payment Arrangement, Expense 242.00M 2025-01-01 → 2025-12-31
Derivative Asset, Not Offset, Policy Election Deduction 160.00M as of 2025-12-31
APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition 230.00M 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 2.42B 2025-01-01 → 2025-12-31
Share-based Payment Arrangement, Expense, Tax Benefit 38.00M 2025-01-01 → 2025-12-31
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount 209.10M as of 2025-12-31
Inventory, Finished Goods, Net of Reserves 8.72B as of 2025-12-31
Inventory, Work in Process, Net of Reserves 1.60B as of 2025-12-31
Inventory, Raw Materials, Net of Reserves 7.43B as of 2025-12-31
Inventory, Supplies, Net of Reserves 378.00M as of 2025-12-31
Contract with Customer, Liability, Revenue Recognized 1.89B 2025-01-01 → 2025-12-31
Contract with Customer, Liability, Cumulative Catch-up Adjustment to Revenue, Change in Estimate of Transaction Price -497.00M 2025-01-01 → 2025-12-31
Equity Securities, FV-NI, Unrealized Gain (Loss) 20.00M 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 179.00M 2025-01-01 → 2025-12-31
Line of Credit Facility, Maximum Borrowing Capacity 15.84B as of 2025-12-31
Line of Credit Facility, Remaining Borrowing Capacity 9.66B as of 2025-12-31
Liability, Pension and Other Postretirement and Postemployment Benefits, Noncurrent 3.84B as of 2025-12-31
SegmentExpenditureAdditionToLongLivedAssets 4.29B 2025-01-01 → 2025-12-31
Dividends, Common Stock, Cash 2.79B 2025-01-01 → 2025-12-31
Contract with Customer, Receivable, after Allowance for Credit Loss, Current 9.40B as of 2025-12-31
Common Stocks, Including Additional Paid in Capital 7.18B as of 2025-12-31
Contract with Customer, Receivable, after Allowance for Credit Loss, Noncurrent 1.01B as of 2025-12-31
SupplierFinanceProgramObligationIncrease 5.67B 2025-01-01 → 2025-12-31
SupplierFinanceProgramObligationDecreaseSettlement 5.56B 2025-01-01 → 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year One 98.00M as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Two 35.00M as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Three 27.00M as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Four 24.00M as of 2025-12-31
Revenue, Remaining Performance Obligation, Amount 30.10B as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, Year Five 21.00M as of 2025-12-31
Finite-Lived Intangible Asset, Expected Amortization, after Year Five 36.00M as of 2025-12-31
Guarantor Obligations, Maximum Exposure, Undiscounted 458.00M as of 2025-12-31
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One 744.00M as of 2025-12-31
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year One Through Five 1.49B as of 2025-12-31
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 378.00M as of 2025-12-31
Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 202.00M as of 2025-12-31
Treasury Stock, Value, Acquired, Cost Method 5.19B 2025-01-01 → 2025-12-31
Derivative Liability, Not Offset, Policy Election Deduction 160.00M as of 2025-12-31
Derivative, Notional Amount 29.30B as of 2025-12-31
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One 748.00M as of 2025-12-31
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five 1.50B as of 2025-12-31
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 383.00M as of 2025-12-31
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 202.00M as of 2025-12-31
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) 185.00M 2025-01-01 → 2025-12-31
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss 0 as of 2025-12-31
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss 26.00M as of 2025-12-31
Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss 26.00M as of 2025-12-31
Standard and Extended Product Warranty Accrual 1.63B as of 2025-12-31
Defined Benefit Plan, Benefit Obligation, Actuarial Gain (Loss) 294.00M 2025-01-01 → 2025-12-31
Standard and Extended Product Warranty Accrual, Increase for Warranties Issued 762.00M 2025-01-01 → 2025-12-31
Standard and Extended Product Warranty Accrual, Decrease for Payments 836.00M 2025-01-01 → 2025-12-31
Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain (Loss), before Tax 14.00M as of 2025-12-31
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months 177.00M as of 2025-12-31
Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer 763.00M as of 2025-12-31
Debt Securities, Available-for-sale, Unrealized Loss Position 940.00M as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value 1.06B as of 2025-12-31
Derivative Asset, Fair Value, Amount Offset Against Collateral 336.00M as of 2025-12-31
Financing Receivable, Allowance for Credit Loss, Recovery 47.00M 2025-01-01 → 2025-12-31
Derivative Liability, Fair Value, Amount Offset Against Collateral 165.00M as of 2025-12-31
Financing Receivable, Allowance for Credit Loss, Writeoff 148.00M 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value 867.00M as of 2025-12-31
Deferred Tax Assets, Tax Credit Carryforwards 1.30B as of 2025-12-31
Goodwill, Translation and Purchase Accounting Adjustments 80.00M 2025-01-01 → 2025-12-31
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Postretirement Benefits 425.00M as of 2025-12-31
Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation 607.00M as of 2025-12-31
Goodwill, Gross 7.44B as of 2025-12-31
Operating Lease, Cost 192.00M 2025-01-01 → 2025-12-31
Goodwill, Impaired, Accumulated Impairment Loss 2.12B as of 2025-12-31
Short-term Lease, Cost 67.00M 2025-01-01 → 2025-12-31
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 259.00M 2025-01-01 → 2025-12-31
Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Warranty Reserves 287.00M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year One 183.00M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Two 149.00M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Three 115.00M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Four 98.00M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, Year Five 74.00M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid, after Year Five 223.00M as of 2025-12-31
Lessee, Operating Lease, Liability, to be Paid 842.00M as of 2025-12-31
Deferred Tax Assets, Other 579.00M as of 2025-12-31
Deferred Tax Assets, Gross 4.90B as of 2025-12-31
Deferred Tax Assets, Valuation Allowance 840.00M as of 2025-12-31
Deferred Tax Assets, Net of Valuation Allowance 2.76B as of 2025-12-31
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 114.00M as of 2025-12-31
Deferred Tax Liabilities, Gross 1.79B as of 2025-12-31
Deferred Tax Assets, Net 2.26B as of 2025-12-31
Debt and Equity Securities, Gain (Loss) 30.00M 2025-01-01 → 2025-12-31
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year One 6.00M as of 2025-12-31
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Two 5.00M as of 2025-12-31
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Three 5.00M as of 2025-12-31
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Four 5.00M as of 2025-12-31
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, Year Five 4.00M as of 2025-12-31
Defined Benefit Plan, Expected Future Prescription Drug Subsidy Receipt, after Year Five 17.00M as of 2025-12-31
Deferred Tax Liabilities, Other 429.00M as of 2025-12-31
Hedged Liability, Fair Value Hedge 6.12B as of 2025-12-31
Hedged Liability, Fair Value Hedge, Cumulative Increase (Decrease) -34.00M as of 2025-12-31
Long-Term Debt, Maturity, Year One 7.12B as of 2025-12-31
Defined Contribution Plan, Cost 835.00M 2025-01-01 → 2025-12-31
Long-Term Debt, Maturity, Year Two 8.92B as of 2025-12-31
Long-Term Debt, Maturity, Year Three 7.75B as of 2025-12-31
Long-Term Debt, Maturity, Year Four 3.11B as of 2025-12-31
Long-Term Debt, Maturity, Year Five 1.26B as of 2025-12-31
Unrecognized Tax Benefits 1.35B as of 2025-12-31
Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions 35.00M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 6.00M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 68.00M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 29.00M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations 10.00M 2025-01-01 → 2025-12-31
Unrecognized Tax Benefits that Would Impact Effective Tax Rate 1.20B as of 2025-12-31
Lessor, Operating Lease, Payment to be Received, Year One 896.00M as of 2025-12-31
Lessor, Operating Lease, Payment to be Received, Year Two 598.00M as of 2025-12-31
Lessor, Operating Lease, Payment to be Received, Year Three 397.00M as of 2025-12-31
Lessor, Operating Lease, Payment to be Received, Year Four 200.00M as of 2025-12-31
Lessor, Operating Lease, Payment to be Received, Year Five 104.00M as of 2025-12-31
Lessor, Operating Lease, Payment to be Received, after Year Five 80.00M as of 2025-12-31
Lessor, Operating Lease, Payments to be Received 2.27B as of 2025-12-31
Income Tax Examination, Penalties and Interest Expense 67.00M 2025-01-01 → 2025-12-31
Income Tax Examination, Penalties and Interest Accrued 268.00M as of 2025-12-31
Income (Loss) from Continuing Operations before Income Taxes, Domestic 5.41B 2025-01-01 → 2025-12-31
Income (Loss) from Continuing Operations before Income Taxes, Foreign 6.13B 2025-01-01 → 2025-12-31
Debt Securities, Available-for-sale, Amortized Cost 3.54B as of 2025-12-31
Derivative Liability, Fair Value, Gross Liability 325.00M as of 2025-12-31
Derivative Asset, Fair Value, Gross Asset 496.00M as of 2025-12-31
APIC, Share-based Payment Arrangement, Increase for Cost Recognition 242.00M 2025-01-01 → 2025-12-31
Unit shares · 10 concepts
Label Value Period
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized 42.50M as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant 39.34M as of 2025-12-31
Treasury Stock, Shares, Acquired 14.08M 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number 3.02M as of 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 299,523 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 997,947 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 17,385 2025-01-01 → 2025-12-31
Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 2.30M 2025-01-01 → 2025-12-31
Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable 2.28M as of 2025-12-31
Employee Stock Ownership Plan (ESOP), Number of Allocated Shares 9.60M as of 2025-12-31
Unit US$ / share · 5 concepts
Label Value Period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price $220.52 as of 2025-12-31
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price $331.62 2025-01-01 → 2025-12-31
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price $159.25 2025-01-01 → 2025-12-31
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price $232.23 2025-01-01 → 2025-12-31
Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $192.44 as of 2025-12-31
Unit pure · 4 concepts
Label Value Period
Percentage of LIFO Inventory 0.7 as of 2025-12-31
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent 0.015 2025-01-01 → 2025-12-31
Effective Income Tax Rate Reconciliation, Percent 0.24 2025-01-01 → 2025-12-31
Unit Rate · 1 concept
Label Value Period
Operating Lease, Weighted Average Discount Rate, Percent 0.04 as of 2025-12-31
Unit segment · 1 concept
Label Value Period
Number of Operating Segments 5 2025-01-01 → 2025-12-31

Other

3 concepts 2 units
Unit US$ · 2 concepts
Label Value Period
Stockholders' Equity, Other 5.00M 2025-01-01 → 2025-12-31
Entity Public Float 180.90B as of 2025-12-31
Unit shares · 1 concept
Label Value Period
Entity Common Stock, Shares Outstanding 465.29M as of 2025-12-31

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (CAT CIK 0000018230), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.